The early clinical screening methods of HCC are mainly alpha-fetoprotein (AFP) determination and liver ultrasonography, but the sensitivity and specificity of AFP detection are limited, while ultrasonography largely depends on the subjective judgment of the operator, and conventional ultrasound does not provide sufficient information for determining the nature of liver lesions2–4. Here, AFP is linked to hepatocellular carcinoma.